Translesional synthesis on DNA templates containing an estrogen quinone-derived adduct:: N2-(2-hydroxyestron-6-yl)-2′-deoxyguanosine and N6-(2-hydroxyestron-6-yl)-2′-deoxyadenosine

被引:22
作者
Terashima, I
Suzuki, N
Dasaradhi, L
Tan, CK
Downey, KM
Shibutani, S [1 ]
机构
[1] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
[2] Univ Miami, Sch Med, Dept Med & Biochem, Miami, FL 33101 USA
关键词
D O I
10.1021/bi981235e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Miscoding properties induced by estrogen quinone-derived DNA adducts were analyzed using an in vitro experimental system to quantify base substitutions and deletions. Site-specifically modified oligodeoxynucleotides containing a single N-2-(2-hydroxyestron-6-yl)-2'-deoxyguanosine (2-OHE1-N-2-dG) or N-6-(2-hydroxyestron-6-yl)-2'-deoxyadenosine (2-OHE1-N-6-dA) were prepared postsynthetically and used as templates in primer extension reactions catalyzed by mammalian DNA polymerases (pol) alpha, beta, and delta. The 2-OHE1-N-2-dG adduct blocked primer extension reactions more strongly than 2-OHE1-N-6-dA. Using pol alpha and delta, 2-OHE1-N-2-dG promoted incorporation of dCMP (6.3 and 3.1%, respectively), the correct base, opposite the lesion: when pol delta was used, misincorporation of dTMP (0.52%) was detected. 2-OHE1N6-dA also promoted incorporation of dTMP, the correct base, opposite the lesion, accompanied by misincorporation of dCTP (0.54% for pol alpha and 3.2% for pol delta) and one-base deletion (0.3-0.5%), Using pol beta, no miscoding was detected. The miscoding occurred only when replicative DNA polymerases were used. Kinetic data were consistent with those obtained from the analysis of fully extended products formed by pol alpha or pol beta. These results indicate that endogenous estrogen quinone-derived DNA adducts have miscoding potential: G --> A and A --> G transitions and deletions are predicted in mammalian cells.
引用
收藏
页码:13807 / 13815
页数:9
相关论文
共 54 条
[1]   DOES A GENOTOXIC CARCINOGEN CONTRIBUTE TO HUMAN BREAST-CANCER - THE VALUE OF MUTATIONAL SPECTRA IN UNRAVELING THE ETIOLOGY OF CANCER [J].
BIGGS, PJ ;
WARREN, W ;
VENITT, S ;
STRATTON, MR .
MUTAGENESIS, 1993, 8 (04) :275-283
[2]   NOVEL PATTERN OF P53 GENE-MUTATIONS IN AN AMERICAN BLACK COHORT WITH HIGH MORTALITY FROM BREAST-CANCER [J].
BLASZYK, H ;
VAUGHN, CB ;
HARTMANN, A ;
MCGOVERN, RM ;
SCHROEDER, JJ ;
CUNNINGHAM, J ;
SCHAID, D ;
SOMMER, SS ;
KOVACH, JS .
LANCET, 1994, 343 (8907) :1195-1197
[3]   Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators [J].
Cavalieri, EL ;
Stack, DE ;
Devanesan, PD ;
Todorovic, R ;
Dwivedy, I ;
Higginbotham, S ;
Johansson, SL ;
Patil, KD ;
Gross, ML ;
Gooden, JK ;
Ramanathan, R ;
Cerny, RL ;
Rogan, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10937-10942
[4]   NOVEL BLUNT-END ADDITION-REACTIONS CATALYZED BY DNA-POLYMERASE-I OF ESCHERICHIA-COLI [J].
CLARK, JM ;
JOYCE, CM ;
BEARDSLEY, GP .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 198 (01) :123-127
[5]  
COLES C, 1992, CANCER RES, V52, P5291
[6]   SYNTHESIS AND CHARACTERIZATION OF ESTROGEN 2,3-QUINONES AND 3,4-QUINONES - COMPARISON OF DNA ADDUCTS FORMED BY THE QUINONES VERSUS HORSERADISH PEROXIDASE-ACTIVATED CATECHOL ESTROGENS [J].
DWIVEDY, I ;
DEVANESAN, P ;
CREMONESI, P ;
ROGAN, E ;
CAVALIERI, E .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (06) :828-833
[7]   SINGLE-BASE PAIR GERM-LINE DELETION IN THE P53 GENE IN A CANCER PREDISPOSED FAMILY [J].
HAMELIN, R ;
BARICHARD, F ;
HENRY, I ;
JUNIEN, C ;
THOMAS, G .
HUMAN GENETICS, 1994, 94 (01) :88-90
[8]  
HAN XL, 1994, CANCER RES, V54, P5515
[9]  
Hayashi N, 1996, MOL CARCINOGEN, V16, P149, DOI 10.1002/(SICI)1098-2744(199607)16:3<149::AID-MC5>3.3.CO
[10]  
2-#